Venture Life Group Aktie

Venture Life Group AAQS 2024

Venture Life Group AAQS

3

Ticker

VLG.L

ISIN

GB00BFPM8908

WKN

A110ZQ

Venture Life Group har en aktuel AAQS på 3. En høj AAQS kan betragtes som et positivt tegn på, at virksomheden udvikler sig succesfuldt. Investorerne kan forvente, at virksomheden er på rette spor mod at skabe overskud. På den anden side er det vigtigt at betragte AAQS for aktien Venture Life Group i forhold til de opnåede overskud og sammenligne med andre virksomheder i samme branche. En høj AAQS er ikke en absolut garanti for en positiv fremtid. Det er kun på den måde, man kan få et komplet billede af virksomhedens præstationer. For bedre at kunne vurdere virksomhedens udvikling er det vigtigt at betragte AAQS i sammenligning med andre virksomheder i samme branche. Generelt bør investorer altid betragte en virksomheds AAQS i sammenhæng med andre nøgletal som overskud, EBIT, cash flow og andre for at træffe en velbaseret investeringsbeslutning.

Venture Life Group Aktienanalyse

Hvad gør Venture Life Group?

The Venture Life Group PLC was founded in 2010 and is based in the United Kingdom. This company operates in the health and wellness industry and specializes in the development, manufacturing, and marketing of lifestyle products. Venture Life's business model is based on developing products that can simplify and enhance people's everyday lives. This includes not only dietary supplements and medical devices, but also beauty and skincare products, as well as insect repellents. The company is divided into various divisions, each focusing on different products. Venture Life Europe, the company's main pillar, focuses on dietary supplements and medical devices. This includes products such as sterile wound dressings and blood glucose monitors. The Southern Europe division specializes in dermatology products and insect repellents. In North America, Venture Life operates through its subsidiary Biokosmes, specializing in beauty and skincare products. Other divisions of the company, such as Nordic Life Science and Farma Mediterranea, produce dietary supplements and collagen products. The company offers a wide range of products, including products like Just for Tummies, which are designed to support the immune and digestive systems, and Dentyl pH, which promotes lasting oral hygiene. Another product range from Venture Life is UltraDEX, which focuses on tongue and dental health, as well as oral care. Another product is the insect repellent Mosi-Guard, which is offered in various forms such as lotion, spray, and roll-on. In recent years, Venture Life has also made acquisitions to strengthen its presence in specific markets and expand its product range. These acquisitions include UltraDex, a company focused on oral hygiene, and PharmaSource, a supplier of pharmaceutical raw materials. Under the leadership of Jerry Randall, Venture Life has developed an experienced management team and a strong strategy for expanding into new markets and product categories. The company has an extensive network of customers and distribution partners and has built its reputation on high-quality products and excellent customer service. Overall, Venture Life Group PLC is an innovative company with a wide range of products that focuses on improving its customers' daily lives. With a strong strategy and experienced leadership team, the company has established a good position in the industry and looks optimistically towards the future. Venture Life Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Ofte stillede spørgsmål om Venture Life Group aktien

Aktiespareplaner tilbyder en attraktiv mulighed for investorer at opbygge formue på lang sigt. En af de største fordele er den såkaldte cost-average-effekt: Ved regelmæssigt at investere et fast beløb i aktier eller aktiefonde, køber man automatisk flere andele, når priserne er lave, og færre, når de er høje. Dette kan føre til en mere fordelagtig gennemsnitspris per andel over tid. Desuden giver aktiespareplaner også småinvestorer adgang til dyre aktier, da de kan deltage med små beløb. Den regelmæssige investering fremmer også en disciplineret investeringsstrategi og hjælper med at undgå følelsesladede beslutninger, som impulsiv køb eller salg. Derudover drager investorer fordel af den potentielle værdistigning af aktierne samt af udbytteudlodninger, der kan geninvesteres, hvilket forstærker renters rente effekten og dermed væksten af det investerede kapital.

Andere Kennzahlen von Venture Life Group

Vores aktieanalyse af Venture Life Group Omsætning-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Venture Life Group Omsætning. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: